| Target Price | $328.95 |
| Price | $257.85 |
| Potential | 27.57% |
| Number of Estimates | 50 |
| 50 Analysts have issued a price target Salesforce 2026 . The average Salesforce target price is $328.95. This is 27.57% higher than the current stock price. The highest price target is $464.10 79.99% , the lowest is $225.23 12.65% . | |
| A rating was issued by 58 analysts: 44 Analysts recommend Salesforce to buy, 13 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Salesforce stock has an average upside potential 2026 of 27.57% . Most analysts recommend the Salesforce stock at Purchase. |
55 Analysts have issued a sales forecast Salesforce 2026 . The average Salesforce sales estimate is $41.7b . This is 3.33% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $43.6b 8.20% , the lowest is $40.3b 0.01% .
This results in the following potential growth metrics:
| 2025 | $37.9b | 8.72% |
|---|---|---|
| 2026 | $41.7b | 9.94% |
| 2027 | $45.4b | 9.01% |
| 2028 | $49.6b | 9.18% |
| 2029 | $54.8b | 10.59% |
| 2030 | $60.0b | 9.39% |
| 2031 | $65.6b | 9.42% |
| 2032 | $72.2b | 10.01% |
| 2033 | $79.6b | 10.18% |
26 Analysts have issued an Salesforce EBITDA forecast 2026. The average Salesforce EBITDA estimate is $17.3b . This is 76.73% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $18.6b 89.60% , the lowest is $15.7b 60.03% .
This results in the following potential growth metrics and future EBITDA Margins:
| 2025 | $8.6b | 24.34% |
|---|---|---|
| 2026 | $17.3b | 102.26% |
| 2027 | $19.1b | 10.04% |
| 2028 | $21.1b | 10.43% |
| 2029 | $23.0b | 9.21% |
| 2030 | $26.0b | 12.96% |
| 2031 | $17.8b | 31.39% |
| 2032 | $19.7b | 10.49% |
| 2033 | $21.7b | 10.29% |
| 2025 | 22.61% | 14.37% |
|---|---|---|
| 2026 | 41.59% | 83.97% |
| 2027 | 41.99% | 0.96% |
| 2028 | 42.46% | 1.12% |
| 2029 | 41.93% | 1.25% |
| 2030 | 43.30% | 3.27% |
56 Salesforce Analysts have issued a net profit forecast 2026. The average Salesforce net profit estimate is $10.8b . This is 49.83% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $11.5b 59.69% , the lowest is $10.3b 42.78% .
This results in the following potential growth metrics and future Net Margins:
| 2025 | $6.2b | 49.83% |
|---|---|---|
| 2026 | $10.8b | 74.61% |
| 2027 | $12.1b | 11.88% |
| 2028 | $13.8b | 13.77% |
| 2029 | $16.0b | 16.29% |
| 2030 | $18.2b | 13.56% |
| 2031 | $20.3b | 11.61% |
| 2032 | $22.7b | 11.98% |
| 2033 | $25.8b | 13.58% |
| 2025 | 16.35% | 37.82% |
|---|---|---|
| 2026 | 25.97% | 58.81% |
| 2027 | 26.66% | 2.66% |
| 2028 | 27.78% | 4.20% |
| 2029 | 29.21% | 5.15% |
| 2030 | 30.32% | 3.80% |
| 2031 | 30.93% | 2.01% |
| 2032 | 31.48% | 1.78% |
| 2033 | 32.45% | 3.08% |
56 Analysts have issued a Salesforce forecast for earnings per share. The average Salesforce EPS is $11.49 . This is 51.58% higher than earnings per share in the financial year 2025. The highest EPS forecast is $12.24 61.48% , the lowest is $10.95 44.46% .
This results in the following potential growth metrics and future valuations:
| 2025 | $6.36 | 51.43% |
|---|---|---|
| 2026 | $11.49 | 80.66% |
| 2027 | $12.85 | 11.84% |
| 2028 | $14.62 | 13.77% |
| 2029 | $17.00 | 16.28% |
| 2030 | $19.31 | 13.59% |
| 2031 | $21.55 | 11.60% |
| 2032 | $24.13 | 11.97% |
| 2033 | $27.41 | 13.59% |
| Current | 34.02 | 40.95% |
|---|---|---|
| 2026 | 22.45 | 34.00% |
| 2027 | 20.06 | 10.65% |
| 2028 | 17.64 | 12.06% |
| 2029 | 15.17 | 14.00% |
| 2030 | 13.36 | 11.93% |
| 2031 | 11.97 | 10.40% |
| 2032 | 10.69 | 10.69% |
| 2033 | 9.41 | 11.97% |
Based on analysts' sales estimates for 2026, the Salesforce stock is valued at an EV/Sales of 5.73 and an P/S ratio of 5.80 .
This results in the following potential growth metrics and future valuations:
| Current | 5.92 | 34.22% |
|---|---|---|
| 2026 | 5.73 | 3.21% |
| 2027 | 5.26 | 8.26% |
| 2028 | 4.81 | 8.41% |
| 2029 | 4.35 | 9.57% |
| 2030 | 3.98 | 8.59% |
| 2031 | 3.64 | 8.60% |
| 2032 | 3.31 | 9.11% |
| 2033 | 3.00 | 9.24% |
| Current | 5.99 | 34.27% |
|---|---|---|
| 2026 | 5.80 | 3.23% |
| 2027 | 5.32 | 8.26% |
| 2028 | 4.87 | 8.41% |
| 2029 | 4.41 | 9.57% |
| 2030 | 4.03 | 8.59% |
| 2031 | 3.68 | 8.61% |
| 2032 | 3.35 | 9.10% |
| 2033 | 3.04 | 9.24% |
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BTIG |
➜
Buy
|
Initiated | Dec 17 2025 |
| Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Dec 09 2025 |
| Citigroup |
Neutral
➜
Neutral
|
Unchanged | Dec 08 2025 |
| DA Davidson |
Neutral
➜
Neutral
|
Unchanged | Dec 05 2025 |
| Baird |
Outperform
➜
Outperform
|
Unchanged | Dec 04 2025 |
| BMO Capital |
Outperform
➜
Outperform
|
Unchanged | Dec 04 2025 |
| Citizens |
Market Outperform
➜
Market Outperform
|
Unchanged | Dec 04 2025 |
| Analyst Rating | Date |
|---|---|
|
Initiated
BTIG:
➜
Buy
|
Dec 17 2025 |
|
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Dec 09 2025 |
|
Unchanged
Citigroup:
Neutral
➜
Neutral
|
Dec 08 2025 |
|
Unchanged
DA Davidson:
Neutral
➜
Neutral
|
Dec 05 2025 |
|
Unchanged
Baird:
Outperform
➜
Outperform
|
Dec 04 2025 |
|
Unchanged
BMO Capital:
Outperform
➜
Outperform
|
Dec 04 2025 |
|
Unchanged
Citizens:
Market Outperform
➜
Market Outperform
|
Dec 04 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


